LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | CGP60474 | 10 | uM | LJP6 | 2 | G01 | 72 | hr | 2543 | 840 | 5438 | 0.1545 | -0.6360 |
| SK-BR-3 | CGP60474 | 10 | uM | LJP6 | 3 | G01 | 72 | hr | 2543 | 707 | 5557 | 0.1272 | -0.6787 |
| SK-BR-3 | CGP60474 | 10 | uM | LJP5 | 1 | F01 | 72 | hr | 2543 | 1042 | 5734 | 0.1817 | -0.5327 |
| SK-BR-3 | CGP60474 | 10 | uM | LJP5 | 2 | F01 | 72 | hr | 2543 | 1127 | 5761 | 0.1956 | -0.4984 |
| SK-BR-3 | CGP60474 | 10 | uM | LJP5 | 3 | F01 | 72 | hr | 2543 | 967 | 5760 | 0.1679 | -0.5595 |
| SK-BR-3 | PD173074 | 0.04 | uM | LJP6 | 1 | I12 | 72 | hr | 2543 | 5339 | 5258 | 1.0152 | 1.0291 |
| SK-BR-3 | PD173074 | 0.04 | uM | LJP6 | 2 | I12 | 72 | hr | 2543 | 5558 | 5438 | 1.0220 | 1.0402 |
| SK-BR-3 | PD173074 | 0.04 | uM | LJP6 | 3 | I12 | 72 | hr | 2543 | 5972 | 5557 | 1.0746 | 1.1318 |
| SK-BR-3 | PD173074 | 0.12 | uM | LJP6 | 1 | I11 | 72 | hr | 2543 | 5365 | 5258 | 1.0202 | 1.0385 |
| SK-BR-3 | PD173074 | 0.12 | uM | LJP6 | 2 | I11 | 72 | hr | 2543 | 5793 | 5438 | 1.0653 | 1.1187 |
| SK-BR-3 | PD173074 | 0.12 | uM | LJP6 | 3 | I11 | 72 | hr | 2543 | 5711 | 5557 | 1.0276 | 1.0490 |
| SK-BR-3 | PD173074 | 0.37 | uM | LJP6 | 1 | I10 | 72 | hr | 2543 | 5339 | 5258 | 1.0152 | 1.0291 |
| SK-BR-3 | PD173074 | 0.37 | uM | LJP6 | 2 | I10 | 72 | hr | 2543 | 5523 | 5438 | 1.0156 | 1.0284 |
| SK-BR-3 | PD173074 | 0.37 | uM | LJP6 | 3 | I10 | 72 | hr | 2543 | 5737 | 5557 | 1.0323 | 1.0572 |
| SK-BR-3 | PD173074 | 1.11 | uM | LJP6 | 1 | I09 | 72 | hr | 2543 | 5160 | 5258 | 0.9812 | 0.9641 |
| SK-BR-3 | PD173074 | 1.11 | uM | LJP6 | 2 | I09 | 72 | hr | 2543 | 5733 | 5438 | 1.0542 | 1.0987 |
| SK-BR-3 | PD173074 | 1.11 | uM | LJP6 | 3 | I09 | 72 | hr | 2543 | 5804 | 5557 | 1.0444 | 1.0785 |
| SK-BR-3 | PD173074 | 3.33 | uM | LJP6 | 1 | I08 | 72 | hr | 2543 | 5386 | 5258 | 1.0242 | 1.0461 |
| SK-BR-3 | PD173074 | 3.33 | uM | LJP6 | 2 | I08 | 72 | hr | 2543 | 5690 | 5438 | 1.0463 | 1.0843 |
| SK-BR-3 | PD173074 | 3.33 | uM | LJP6 | 3 | I08 | 72 | hr | 2543 | 5774 | 5557 | 1.0390 | 1.0690 |
| SK-BR-3 | PD173074 | 10 | uM | LJP6 | 1 | I07 | 72 | hr | 2543 | 2399 | 5258 | 0.4562 | -0.0543 |
| SK-BR-3 | PD173074 | 10 | uM | LJP6 | 2 | I07 | 72 | hr | 2543 | 2699 | 5438 | 0.4963 | 0.0556 |
| SK-BR-3 | PD173074 | 10 | uM | LJP6 | 3 | I07 | 72 | hr | 2543 | 2504 | 5557 | 0.4506 | -0.0138 |
| SK-BR-3 | Crizotinib | 0.04 | uM | LJP5 | 1 | A24 | 72 | hr | 2543 | 3990 | 5734 | 0.6958 | 0.4680 |
| SK-BR-3 | Crizotinib | 0.04 | uM | LJP5 | 2 | A24 | 72 | hr | 2543 | 4002 | 5761 | 0.6946 | 0.4685 |